DURECT Corporation (NASDAQ:DRRX) announced financial results for the second quarter of 2016. Total revenues were $3.
Healthcare analysts weighed in on shares of DURECT Corporation (NASDAQ:DRRX) after the biotech reported its 2016 first quarter financial results last week. At this …
DURECT Corporation (NASDAQ:DRRX) announced that it is offering, subject to market conditions, shares of its common stock in an underwritten public offering. DURECT anticipates …
In a research report released Tuesday, Cantor analyst Irina Rivkind initiated coverage on shares of DURECT Corporation (NASDAQ:DRRX) with a Hold rating and a price …
